Archives

Paul Liknaitzky hopes for “rigorous research that is neither biased toward panacea thinking, nor ignorant of the best-practice track record and literature to date”. “This field has suffered from [...]

Psilocybin, the psychoactive compound from magic mushrooms, is being used to treat depression and anxiety in terminally ill patients in a new trial at Melbourne’s St Vincent’s Hospital.